118 related articles for article (PubMed ID: 9708963)
1. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection.
Oliva R; Tolosa E; Ezquerra M; Molinuevo JL; Valldeoriola F; Burguera J; Calopa M; Villa M; Ballesta F
Arch Neurol; 1998 Aug; 55(8):1122-4. PubMed ID: 9708963
[TBL] [Abstract][Full Text] [Related]
2. The tau gene A0 allele and progressive supranuclear palsy.
Hoenicka J; Pérez M; Pérez-Tur J; Barabash A; Godoy M; Vidal L; Astarloa R; Avila J; Nygaard T; de Yébenes JG
Neurology; 1999 Oct; 53(6):1219-25. PubMed ID: 10522876
[TBL] [Abstract][Full Text] [Related]
3. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
[TBL] [Abstract][Full Text] [Related]
4. Progressive supranuclear palsy: earlier age of onset in patients with the tau protein A0/A0 genotype.
Molinuevo JL; Valldeoriola F; Alegret M; Oliva R; Tolosa E
J Neurol; 2000 Mar; 247(3):206-8. PubMed ID: 10787116
[TBL] [Abstract][Full Text] [Related]
5. The tau A0 allele in Parkinson's disease.
Golbe LI; Lazzarini AM; Spychala JR; Johnson WG; Stenroos ES; Mark MH; Sage JI
Mov Disord; 2001 May; 16(3):442-7. PubMed ID: 11391737
[TBL] [Abstract][Full Text] [Related]
6. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium.
Bennett P; Bonifati V; Bonuccelli U; Colosimo C; De Mari M; Fabbrini G; Marconi R; Meco G; Nicholl DJ; Stocchi F; Vanacore N; Vieregge P; Williams AC
Neurology; 1998 Oct; 51(4):982-5. PubMed ID: 9781517
[TBL] [Abstract][Full Text] [Related]
7. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy.
Conrad C; Amano N; Andreadis A; Xia Y; Namekataf K; Oyama F; Ikeda K; Wakabayashi K; Takahashi H; Thal LJ; Katzman R; Shackelford DA; Matsushita M; Masliah E; Sawa A
Neurosci Lett; 1998 Jul; 250(2):135-7. PubMed ID: 9697937
[TBL] [Abstract][Full Text] [Related]
8. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy.
Litvan I; Baker M; Hutton M
Neurology; 2001 Jul; 57(1):138-40. PubMed ID: 11445645
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans.
Ezquerra M; Pastor P; Valldeoriola F; Molinuevo JL; Blesa R; Tolosa E; Oliva R
Neurosci Lett; 1999 Nov; 275(3):183-6. PubMed ID: 10580705
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K
Eur J Neurol; 2002 Sep; 9(5):485-9. PubMed ID: 12220379
[TBL] [Abstract][Full Text] [Related]
11. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
Kowalska A; Jamrozik Z; Kwieciński H
Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
[TBL] [Abstract][Full Text] [Related]
12. Significant association between the tau gene A0/A0 genotype and Parkinson's disease.
Pastor P; Ezquerra M; Muñoz E; Martí MJ; Blesa R; Tolosa E; Oliva R
Ann Neurol; 2000 Feb; 47(2):242-5. PubMed ID: 10665497
[TBL] [Abstract][Full Text] [Related]
13. Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
Baker M; Litvan I; Houlden H; Adamson J; Dickson D; Perez-Tur J; Hardy J; Lynch T; Bigio E; Hutton M
Hum Mol Genet; 1999 Apr; 8(4):711-5. PubMed ID: 10072441
[TBL] [Abstract][Full Text] [Related]
14. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.
Higgins JJ; Litvan I; Pho LT; Li W; Nee LE
Neurology; 1998 Jan; 50(1):270-3. PubMed ID: 9443491
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of tau 3'untranslated region and saitohin gene in sporadic progressive supranuclear palsy.
Ezquerra M; Campdelacreu J; Muñoz E; Oliva R; Tolosa E
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):155-7. PubMed ID: 14707330
[TBL] [Abstract][Full Text] [Related]
16. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
Morris HR; Gibb G; Katzenschlager R; Wood NW; Hanger DP; Strand C; Lashley T; Daniel SE; Lees AJ; Anderton BH; Revesz T
Brain; 2002 May; 125(Pt 5):969-75. PubMed ID: 11960887
[TBL] [Abstract][Full Text] [Related]
17. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy.
Higgins JJ; Golbe LI; De Biase A; Jankovic J; Factor SA; Adler RL
Neurology; 2000 Nov; 55(9):1364-7. PubMed ID: 11087782
[TBL] [Abstract][Full Text] [Related]
18. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
[TBL] [Abstract][Full Text] [Related]
19. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
[TBL] [Abstract][Full Text] [Related]
20. Parkin polymorphisms in progressive supranuclear palsy.
Ros R; Ampuero I; García de Yébenes J
J Neurol Sci; 2008 May; 268(1-2):176-8. PubMed ID: 18022644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
